Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-04-06 @ 8:02 PM
Study NCT ID:
NCT00248560
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2005-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000445589
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |